misonidazole has been researched along with Sensitivity and Specificity in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (12.50) | 18.2507 |
| 2000's | 11 (34.38) | 29.6817 |
| 2010's | 16 (50.00) | 24.3611 |
| 2020's | 1 (3.13) | 2.80 |
| Authors | Studies |
|---|---|
| Calderoni, L; Castellucci, P; Fanti, S; Telo, S; Vichi, S; Zagni, F | 1 |
| Hatazawa, J; Hiraka, T; Hosoya, T; Kanoto, M; Kirii, K; Matsuda, K; Sakurada, K; Sonoda, Y; Sugai, Y; Toyoguchi, Y | 1 |
| Wardman, P | 1 |
| Jiang, H; Jiang, HJ; Li, X; Pan, WB; Wang, YQ; Xu, HL; Zhang, MY; Zhang, RJ | 1 |
| Hosono, M; Ishikawa, K; Kanamori, S; Koike, R; Nakamatsu, K; Nishikawa, T; Nishimura, Y; Shibata, T; Tachibana, I; Tamura, M | 1 |
| Hata, H; Kitagawa, Y; Kuge, Y; Okamoto, S; Sato, J; Shiga, T; Shindoh, M; Tamaki, N; Yamazaki, Y | 1 |
| Aide, N; Berriolo-Riedinger, A; Blagosklonov, O; Brenot-Rossi, I; Bridji, B; Cachin, F; Caignon, JM; Chaumet-Riffaud, P; Collombier, L; Courbon, F; Devillers, A; Doyeux, K; Dubray, B; Fernandez, P; Gremillet, E; Houzard, C; Kolesnikov-Gauthier, H; Modzelewski, R; Olivier, P; Roux, J; Tessonnier, L; Thureau, S; Vera, P; Vervueren, L | 1 |
| de Clermont-Gallerande, H; Fernandez, P; Hatt, M; Henriques de Figueiredo, B; Lamare, F; Merlin, T; Vimont, D | 1 |
| Binns, D; Bressel, M; Corry, J; Fisher, R; Hicks, RJ; McArthur, GA; Peters, LJ; Rischin, D; Solomon, B; Trinkaus, ME; Young, RJ | 1 |
| Porceddu, SV | 1 |
| Dubois, L; Eriksson, J; Lambin, P; Lieuwes, NG; Peeters, SG; van Dongen, GA; van Elmpt, W; Zegers, CM | 1 |
| Hirata, K; Kasai, K; Kuge, Y; Magota, K; Nishijima, KI; Okamoto, S; Onimaru, R; Shiga, T; Shirato, H; Tamaki, N; Tuchiya, K; Watanabe, S; Yasuda, K | 1 |
| Beattie, BJ; Carlin, SD; Grkovski, M; Humm, JL; Lee, NY; Leeman, JE; O'Donoghue, JA; Riaz, N; Schöder, H | 1 |
| Bal, M; Georgi, JC; Humm, JL; Lee, NY; Narayanan, M; Nehmeh, SA; O'Donoghue, J; Paulus, T; Schmidtlein, CR; Wang, W; Zanzonico, PB | 1 |
| Humm, JL; Ling, CC; Nehmeh, SA; Wang, K; Yorke, E | 1 |
| Abolmaali, N; Baumann, M; Haase, R; Koch, A; Kotzerke, J; Steinbach, J; Zips, D; Zöphel, K | 1 |
| Carlin, S; Ling, CC; Lorenzen, S; O'Donoghue, JA; Oehler, C; Russell, J; Zanzonico, P | 1 |
| Blower, PJ; Handley, MG; Medina, RA; Nagel, E; Southworth, R | 1 |
| Deng, A; Du, J; Qiao, J; Yin, W; Zhou, X; Zhu, L | 1 |
| Donnan, G; Kazui, S; Markus, R; Read, S; Reutens, D | 1 |
| Büll, U; Coenen, HH; Dimartino, E; Eble, MJ; Gagel, B; Hamacher, K; Maneschi, P; Pinkawa, M; Reinartz, P; Stanzel, S; Westhofen, M; Zimny, M | 1 |
| Ametamey, SM; Bruehlmeier, M; Roelcke, U; Schubiger, PA | 1 |
| Bares, R; Dittmann, H; Eschmann, SM; Machulla, HJ; Paulsen, F; Reimold, M; Reischl, G; Welz, S | 1 |
| Alber, M; Eschmann, SM; Paulsen, F; Thorwarth, D | 1 |
| Campa, J; Finn, R; Forster, G; Humm, J; Larson, S; Ling, C; Polycarpe-Holman, D; Zanzonico, P | 1 |
| Kaanders, JH; Oyen, WJ; Schinagl, DA | 1 |
| Boerman, OC; Bussink, J; Kaanders, JH; Laverman, P; Lok, J; Oyen, WJ; Philippens, ME; Troost, EG; van der Kogel, AJ | 1 |
| Hicks, RJ; Toner, GC | 1 |
| Caldwell, JH; Johnson, PM; Krohn, KA; Martin, GV; Rasey, JS; Revenaugh, JR | 1 |
| Chang, CP; Chang, CW; Chen, KY; Chou, KL; Chu, LS; Liu, RS; Lui, MT; Wu, LC; Yeh, SH; Yen, SH | 1 |
| Avril, N; Schwaiger, M; Weber, WA | 1 |
| Abbott, DF; Bladin, CF; Donnan, GA; Egan, GF; Hirano, T; McKay, WJ; Read, SJ; Sachinidis, JI; Scott, AM; Tochon-Danguy, HJ | 1 |
5 review(s) available for misonidazole and Sensitivity and Specificity
| Article | Year |
|---|---|
Alternative and New Radiopharmaceutical Agents for Lung Cancer.
Topics: Acetates; Carbon Radioisotopes; Dideoxynucleosides; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Lung Neoplasms; Methionine; Misonidazole; Neoplasm Staging; Neuroendocrine Tumors; Peptides; Peptides, Cyclic; Positron Emission Tomography Computed Tomography; Quinolines; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
Nitroimidazoles as hypoxic cell radiosensitizers and hypoxia probes: misonidazole, myths and mistakes.
Topics: Animals; Cell Hypoxia; Cell Survival; Dose-Response Relationship, Drug; Humans; Misonidazole; Oxygen Consumption; Radiation-Sensitizing Agents; Sensitivity and Specificity; Tumor Hypoxia | 2019 |
PET imaging of cardiac hypoxia: opportunities and challenges.
Topics: Acidosis; Animals; Copper; Copper Radioisotopes; Coronary Artery Disease; Coronary Circulation; Humans; Hypoxia; Misonidazole; Myocardial Ischemia; Myocardium; Oxygen; Positron-Emission Tomography; Radiation-Sensitizing Agents; Rats; Reducing Agents; Sensitivity and Specificity; Thiosemicarbazones; Tissue Distribution | 2011 |
PET for sarcomas other than gastrointestinal stromal tumors.
Topics: Biopsy; Dideoxynucleosides; Disease Progression; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Misonidazole; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2008 |
Relevance of positron emission tomography (PET) in oncology.
Topics: Carbon Radioisotopes; Fluorides; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Methionine; Misonidazole; Neoplasm Staging; Neoplasms; Radioisotopes; Radiopharmaceuticals; Sensitivity and Specificity; Thymidine; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
9 trial(s) available for misonidazole and Sensitivity and Specificity
| Article | Year |
|---|---|
A prospective clinical trial of tumor hypoxia imaging with 18F-fluoromisonidazole positron emission tomography and computed tomography (F-MISO PET/CT) before and during radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Misonidazole; Molecular Imaging; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2013 |
Interobserver agreement of qualitative analysis and tumor delineation of 18F-fluoromisonidazole and 3'-deoxy-3'-18F-fluorothymidine PET images in lung cancer.
Topics: Adult; Aged; Algorithms; Carcinoma, Non-Small-Cell Lung; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Misonidazole; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tumor Burden | 2013 |
Potential of [18F]-fluoromisonidazole positron-emission tomography for radiotherapy planning in head and neck squamous cell carcinomas.
Topics: Aged; Carcinoma, Squamous Cell; Feasibility Studies; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Misonidazole; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Reproducibility of Results; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome; Tumor Burden | 2013 |
Correlation of p16 status, hypoxic imaging using [18F]-misonidazole positron emission tomography and outcome in patients with loco-regionally advanced head and neck cancer.
Topics: Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Cell Hypoxia; Cyclin-Dependent Kinase Inhibitor p16; Fluorine Radioisotopes; Head and Neck Neoplasms; Humans; Male; Middle Aged; Misonidazole; Neoplasm Proteins; Papillomavirus Infections; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Treatment Outcome | 2014 |
The reoxygenation of hypoxia and the reduction of glucose metabolism in head and neck cancer by fractionated radiotherapy with intensity-modulated radiation therapy.
Topics: Adult; Aged; Dose Fractionation, Radiation; Down-Regulation; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Misonidazole; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Conformal; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Tumor Hypoxia | 2016 |
pO(2) Polarography versus positron emission tomography ([(18)F] fluoromisonidazole, [(18)F]-2-fluoro-2'-deoxyglucose). An appraisal of radiotherapeutically relevant hypoxia.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Misonidazole; Oximetry; Oxygen; Oxygen Consumption; Polarography; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
Assessment of hypoxia and perfusion in human brain tumors using PET with 18F-fluoromisonidazole and 15O-H2O.
Topics: Adult; Aged; Blood Flow Velocity; Brain; Brain Neoplasms; Female; Humans; Hypoxia, Brain; Male; Middle Aged; Misonidazole; Oxygen Radioisotopes; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Water | 2004 |
Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Female; Fluorine Radioisotopes; Germany; Head and Neck Neoplasms; Humans; Incidence; Lung Neoplasms; Male; Middle Aged; Misonidazole; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2005 |
A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia.
Topics: Cell Hypoxia; Computer Simulation; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Kinetics; Misonidazole; Models, Biological; Neovascularization, Pathologic; Oxygen; Oxygen Consumption; Radioisotope Dilution Technique; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2005 |
18 other study(ies) available for misonidazole and Sensitivity and Specificity
| Article | Year |
|---|---|
Correlation between hypoxic area in primary brain tumors and WHO grade: differentiation from malignancy using 18F-fluoromisonidazole positron emission tomography.
Topics: Brain Neoplasms; Cerebellum; Female; Humans; Male; Middle Aged; Misonidazole; Positron-Emission Tomography; Sensitivity and Specificity; Tumor Hypoxia | 2018 |
Topics: Animals; Colorectal Neoplasms; Disease Models, Animal; Female; Humans; Liver Neoplasms; Mice; Misonidazole; Neoplasm Invasiveness; Positron-Emission Tomography; Radiographic Image Enhancement; Random Allocation; Sensitivity and Specificity; Xenograft Model Antitumor Assays | 2019 |
18F-fluoromisonidazole PET uptake is correlated with hypoxia-inducible factor-1α expression in oral squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cell Hypoxia; Female; Humans; Male; Middle Aged; Misonidazole; Mouth Neoplasms; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2013 |
Insights into the relationship between HPV/p16 status, hypoxia imaging and treatment outcomes in head and neck cancer.
Topics: Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Cell Hypoxia; Cyclin-Dependent Kinase Inhibitor p16; Fluorine Radioisotopes; Head and Neck Neoplasms; Humans; Male; Middle Aged; Misonidazole; Neoplasm Proteins; Papillomavirus Infections; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Treatment Outcome | 2014 |
A comparative study of the hypoxia PET tracers [¹⁸F]HX4, [¹⁸F]FAZA, and [¹⁸F]FMISO in a preclinical tumor model.
Topics: Animals; Cell Hypoxia; Cell Line, Tumor; Computer Simulation; Imidazoles; Misonidazole; Models, Biological; Nitroimidazoles; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Reproducibility of Results; Rhabdomyosarcoma; Sensitivity and Specificity; Triazoles | 2015 |
Multiparametric Imaging of Tumor Hypoxia and Perfusion with
Topics: Adult; Aged; Aged, 80 and over; Female; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Misonidazole; Multimodal Imaging; Neovascularization, Pathologic; Observer Variation; Oxygen; Perfusion Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tumor Hypoxia | 2017 |
Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging.
Topics: Algorithms; Computer Simulation; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Misonidazole; Models, Biological; Neoplasms; Oxygen; Oxygen Consumption; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2009 |
Modeling acute and chronic hypoxia using serial images of 18F-FMISO PET.
Topics: Acute Disease; Algorithms; Cell Hypoxia; Chronic Disease; Computer Simulation; Head and Neck Neoplasms; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Misonidazole; Models, Biological; Oxygen; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique | 2009 |
Two or four hour [¹⁸F]FMISO-PET in HNSCC. When is the contrast best?
Topics: Carcinoma, Small Cell; Female; Head and Neck Neoplasms; Humans; Image Enhancement; Male; Middle Aged; Misonidazole; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Time Factors | 2011 |
18F-fluromisonidazole PET imaging as a biomarker for the response to 5,6-dimethylxanthenone-4-acetic acid in colorectal xenograft tumors.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Colorectal Neoplasms; Female; HT29 Cells; Humans; Mice; Mice, Nude; Misonidazole; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Xanthones | 2011 |
Dose-response relationships of FMISO between trace dose and various macro-doses in rat by ultra-performance liquid chromatography with mass spectrometry and radioactivity analysis.
Topics: Animals; Area Under Curve; Calibration; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Stability; Half-Life; Injections, Intravenous; Linear Models; Male; Metabolic Clearance Rate; Misonidazole; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2012 |
Penumbral topography in human stroke: methodology and validation of the 'Penumbragram'.
Topics: Aged; Aged, 80 and over; Algorithms; Brain; Brain Ischemia; Brain Mapping; Factor Analysis, Statistical; Female; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Male; Misonidazole; Prognosis; Reference Values; Sensitivity and Specificity; Statistics as Topic; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Animal-specific positioning molds for registration of repeat imaging studies: comparative microPET imaging of F18-labeled fluoro-deoxyglucose and fluoro-misonidazole in rodent tumors.
Topics: Animals; Carcinoma, Squamous Cell; Equipment Design; Equipment Failure Analysis; Fluorodeoxyglucose F18; Humans; Male; Misonidazole; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Rats; Reproducibility of Results; Restraint, Physical; Sensitivity and Specificity; Species Specificity; Subtraction Technique | 2006 |
From anatomical to biological target volumes: the role of PET in radiation treatment planning.
Topics: Cell Hypoxia; Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Misonidazole; Neoplasms; Observer Variation; Patient Care Planning; Positron-Emission Tomography; Radiation Tolerance; Radiopharmaceuticals; Radiotherapy; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2006 |
Correlation of [18F]FMISO autoradiography and pimonidazole [corrected] immunohistochemistry in human head and neck carcinoma xenografts.
Topics: Animals; Autoradiography; Biomarkers, Tumor; Head and Neck Neoplasms; Humans; Mice; Mice, Nude; Misonidazole; Nitroimidazoles; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Comparison of fluorine-18-fluorodeoxyglucose and tritiated fluoromisonidazole uptake during low-flow ischemia.
Topics: Animals; Coronary Circulation; Deoxyglucose; Dogs; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Misonidazole; Myocardial Ischemia; Radionuclide Imaging; Sensitivity and Specificity; Tritium | 1995 |
Detection of anaerobic odontogenic infections by fluorine-18 fluoromisonidazole.
Topics: Bacteria, Anaerobic; Bacterial Infections; Carcinoma; Case-Control Studies; Cell Hypoxia; Dental Caries; Dental Pulp Diseases; Fluorine Radioisotopes; Humans; Misonidazole; Nasopharyngeal Neoplasms; Periodontal Diseases; Predictive Value of Tests; Radiation-Sensitizing Agents; Sensitivity and Specificity; Tomography, Emission-Computed | 1996 |
No evidence of hypoxic tissue on 18F-fluoromisonidazole PET after intracerebral hemorrhage.
Topics: Aged; Aged, 80 and over; Cerebral Hemorrhage; Female; Fluorine Radioisotopes; Humans; Hypoxia, Brain; Male; Misonidazole; Radiation-Sensitizing Agents; Sensitivity and Specificity; Stroke; Tomography, Emission-Computed | 1999 |